Schedule 13G ownership disclosure

ADAPTIVE BIOTECHNOLOGIES CORP

Security class unavailable · CUSIP: 00650F109

Event date: 2019-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
17,332,191
Percent of class
13.9400%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-20-001128
Form type
SC 13G
Filer
Adaptive Biotechnologies Corp
CIK
CIK 1478320
Filed
Feb 14, 2020
Reporting period
Dec 31, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub